MK-1064

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

PharmacokineticsPolysomnography

Phase 1

A Study to Evaluate the Effects of Single Doses of MK-1064 and MK-6096 on Polysomnography (PSG) (MK-1064-003)

CompletedNCT02549027

Merck Sharp & Dohme LLCPolysomnography

Start: 2009-11-06End: 2010-04-06Updated: 2018-10-23

A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of MK-1064 (MK-1064-001)

CompletedNCT02549014

Merck Sharp & Dohme LLCPharmacokinetics

Start: 2009-07-06End: 2009-09-29Updated: 2018-10-23